carbamazepine epoxide has been researched along with Body Weight in 6 studies
carbamazepine epoxide: metabolite of carbamazepine; RN given refers to unlabeled cpd
carbamazepine-10,11-epoxide : An epoxide and metabolite of carbamazepine.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Delavirdine is a non-nucleoside reverse transcriptase inhibitor used in combination regimens for the treatment of HIV-1 infection." | 2.71 | Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals. ( Dicenzo, R; DiFrancesco, R; Fischl, M; Forrest, A; Friedland, G; Morse, GD; Para, M; Pollard, R; Shelton, M; Smith, PF, 2005) |
| "To develop a population pharmacokinetic model to evaluate the effects of variety of covariates on clearance of carbamazepine (CBZ) and its main metabolite carbamazepine-10,11-epoxide (CBZE) in Chinese population." | 1.32 | Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data. ( Jiao, Z; Shi, XJ; Zhao, ZG; Zhong, MK, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, Z | 1 |
| Shi, XJ | 1 |
| Zhao, ZG | 1 |
| Zhong, MK | 1 |
| Smith, PF | 1 |
| Dicenzo, R | 1 |
| Forrest, A | 1 |
| Shelton, M | 1 |
| Friedland, G | 1 |
| Para, M | 1 |
| Pollard, R | 1 |
| Fischl, M | 1 |
| DiFrancesco, R | 1 |
| Morse, GD | 1 |
| Liu, H | 2 |
| Delgado, MR | 2 |
| Hönack, D | 1 |
| Löscher, W | 1 |
| Conti, I | 1 |
| Guiso, G | 1 |
| Urso, R | 1 |
| Caccia, S | 1 |
2 trials available for carbamazepine epoxide and Body Weight
| Article | Year |
|---|---|
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals.
Topics: Adolescent; Adult; Anti-HIV Agents; Body Weight; Carbamazepine; Delavirdine; Double-Blind Method; Dr | 2005 |
Influence of sex, age, weight, and carbamazepine dose on serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites.
Topics: Aging; Body Weight; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Epilep | 1994 |
4 other studies available for carbamazepine epoxide and Body Weight
| Article | Year |
|---|---|
Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Asian People; Body Weight; Carbamazepine; | 2004 |
The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children.
Topics: Aging; Anticonvulsants; Body Weight; Carbamazepine; Child; Chromatography, High Pressure Liquid; Dru | 1994 |
Amygdala-kindling as a model for chronic efficacy studies on antiepileptic drugs: experiments with carbamazepine.
Topics: Amygdala; Animals; Anticonvulsants; Body Temperature; Body Weight; Carbamazepine; Electric Stimulati | 1989 |
Inhibitory and inducing effects of denzimol on carbamazepine metabolism in the rat.
Topics: Animals; Anticonvulsants; Body Weight; Carbamazepine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome | 1987 |